Abstract Background Current approaches to identifying drug-drug interactions (DDIs). include safety studies during drug development and post-marketing surveillance after approval. offer important opportunities to identify potential safety issues. but are unable to provide complete set of all possible DDIs. https://www.jmannino.com/